2022
DOI: 10.1016/j.celrep.2022.111011
|View full text |Cite
|
Sign up to set email alerts
|

Proinflammatory signaling in islet β cells propagates invasion of pathogenic immune cells in autoimmune diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
18
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

4
4

Authors

Journals

citations
Cited by 18 publications
(20 citation statements)
references
References 71 publications
2
18
0
Order By: Relevance
“…It has been shown that inflamed islets cells may limit immune cells activation through PD-L1/PD1 interaction [32,33]. With our experimental model, we confirmed that beta cells express high levels of PD-L1 in inflammatory condition as previously observed [29,49,78]. Interestingly, we demonstrate here that alpha and delta cells also increased Cd274 mRNA, leading to an increase of PD-L1 surface expression confirmed by flow cytometry.…”
Section: Discussionsupporting
confidence: 89%
“…It has been shown that inflamed islets cells may limit immune cells activation through PD-L1/PD1 interaction [32,33]. With our experimental model, we confirmed that beta cells express high levels of PD-L1 in inflammatory condition as previously observed [29,49,78]. Interestingly, we demonstrate here that alpha and delta cells also increased Cd274 mRNA, leading to an increase of PD-L1 surface expression confirmed by flow cytometry.…”
Section: Discussionsupporting
confidence: 89%
“…The effect of HC-5770 to increase PD-L1 levels is likely related to PERK mediated phosphorylation of eIF2α, since we observed that blockade of the p-eIF2α/eIF2B interaction with ISRIB has a similar effect. The role of β cell PD-L1 in dampening the autoimmune attack through its interaction with the receptor PD-1 on immune cells is a highly engaging topic in the context of T1D treatment and islet transplantation, with studies reporting that the PD-L1/PD-1 interaction suppresses the adaptive immune response (55)(56)(57)(58)(59). Conversely, in humans, the use of immune checkpoint inhibitors (which block this interaction) increases the incidence of T1D in genetically susceptible populations (60,61), representing one of the more common immune-related adverse events associated with this therapy.…”
Section: Discussionmentioning
confidence: 99%
“…Elimination of this enzyme reduces the influx of pathogenic immune cells into both the pancreatic lymph nodes and islets and increases the entry of more tolerogenic immune cells into the islets. 1 Given that the draining pancreatic lymph node and pancreas are key sites in the initial priming and activity of autoreactive immune cells, respectively, the precise identification and quantitation of immune cells in these two sites are crucial to understanding how the disease process is proceeding and how intervention might alter the process. In this protocol, we focus on the single cell isolation of immune cells from whole pancreas and pancreatic lymph nodes for mass cytometry, or cytometry by time of flight (CyTOF).…”
Section: Before You Beginmentioning
confidence: 99%